Jacqualyn A. Fouse

2015 - Celgene

In 2015, Jacqualyn A. Fouse earned a total compensation of $8.1M as President Hematology and Oncology at Celgene, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,679,323
Option Awards$1,405,470
Salary$845,667
Stock Awards$2,124,401
Other$18,641
Total$8,073,502

Fouse received $3.7M in non-equity incentive plan, accounting for 46% of the total pay in 2015.

Fouse also received $1.4M in option awards, $845.7K in salary, $2.1M in stock awards and $18.6K in other compensation.

Rankings

In 2015, Jacqualyn A. Fouse's compensation ranked 769th out of 13,638 executives tracked by ExecPay. In other words, Fouse earned more than 94.4% of executives.

ClassificationRankingPercentile
All
769
out of 13,638
94th
Division
Manufacturing
273
out of 5,187
95th
Major group
Chemicals And Allied Products
96
out of 1,857
95th
Industry group
Drugs
75
out of 1,531
95th
Industry
Pharmaceutical Preparations
60
out of 1,179
95th
Source: SEC filing on April 28, 2016.

Fouse's colleagues

We found five more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2015.

2015

Robert Hugin

Celgene

Chief Executive Officer

2015

Mark Alles

Celgene

Chief Operating Officer

2015

Thomas Daniel

Celgene

Chairman

2015

Peter Kellogg

Celgene

Chief Financial Officer

2015

Scott Smith

Celgene

President, Immunology & Inflammation

News

You may also like